ArticleOncotarget2017

microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.

Hirofumi Yoshino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.